Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PTLA | Portola Pharmaceuticals, Inc. | -0.11% | 17.93 | 6.5% | $167.21m | |
| HZNP | Horizon Therapeutics Plc | -3.04% | 48.82 | 6.5% | $144.10m | |
| CTLT | Catalent, Inc. | 1.35% | 79.06 | 2.3% | $137.76m | |
| MYOK | MyoKardia, Inc. | -0.69% | 103.26 | 1.8% | $131.39m | |
| BHC | Bausch Health Cos., Inc. | 1.06% | 19.13 | 0.0% | $126.12m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 1.06% | 19.13 | 14.1% | $112.56m | |
| UTHR | United Therapeutics Corp. | 2.15% | 125.70 | 14.3% | $76.32m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.71% | 76.67 | 16.8% | $63.16m | |
| ARGX | argenx SE | -1.02% | 230.34 | 0.0% | $59.52m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.74% | 118.74 | 2.4% | $57.11m | |
| GWPH | GW Pharmaceuticals Plc | 1.02% | 128.57 | 6.2% | $54.50m | |
| AMRN | Amarin Corp. Plc | -2.78% | 6.64 | 1.6% | $51.62m | |
| AXSM | Axsome Therapeutics, Inc. | -2.05% | 74.25 | 1.9% | $46.44m | |
| PRGO | Perrigo Co. Plc | -1.49% | 55.54 | 6.8% | $42.66m | |
| ICLR | ICON plc | -0.85% | 169.48 | 4.3% | $40.99m |
Company Profile
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.